Giuseppe Pontrelli

Giuseppe Pontrelli

Auto-generated profile, based on publicly available information

Giuseppe Pontrelli

Istituto per le Applicazioni del Calcolo - CNR, Via dei Taurini 19 00185 Rome, Italy

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2019 in Advanced Science
Verified
Journal Article
Open access
PDF file
YWYi Wang
Yi Wang
KZKang Zhang
Kang Zhang
XQXian Qin
Xian Qin
TLTianhan Li
Tianhan Li
JQJuhui Qiu
Juhui Qiu
GWGuixue Wang
Guixue Wang
Cardiovascular disease is the leading cause of mortality worldwide. Atherosclerosis, one of the most common forms of the disease, is characterized by a gradual formation of atherosclerotic plaque, hardening, and narrowing of the arteries. Nanomaterials can serve as powerful delivery platforms for atherosclerosis treatment. However, their therapeutic efficacy is substantially limited in vivo due to nonspecific clearance by the mononuclear phagocytic system. In order to address this limitation, rapamycin (RAP)‐loaded poly(lactic‐co‐glycolic acid) (PLGA) nanoparticles are cloaked with the cell membrane of red blood cells (RBCs), creating superior nanocomplexes with a highly complex functionalized bio‐interface. The resulting biomimetic nanocomplexes exhibit a well‐defined “core–shell” structure with favorable hydrodynamic size and negative surface charge. More importantly, the biomimetic nature of the RBC interface results in less macrophage‐mediated phagocytosis in the blood and enhanced accumulation of nanoparticles in the established atherosclerotic plaques, thereby achieving targeted drug release. The biomimetic nanocomplexes significantly attenuate the progression of atherosclerosis. Additionally, the biomimetic nanotherapy approach also displays favorable safety properties. Overall, this study demonstrates the therapeutic advantages of biomimetic nanotherapy for atherosclerosis treatment, which holds considerable promise as a new generation of drug delivery system for safe and efficient management of atherosclerosis.

1 August 2007 in International Journal of Heat and Mass Transfer
Verified
Journal Article
Closed access
GPGiuseppe Pontrelli
Giuseppe Pontrelli
FMFilippo de Monte
Filippo de Monte

1 November 2015 in Journal of Controlled Release
Verified
Journal Article
Open access
SMSean McGinty
Sean McGinty
GPGiuseppe Pontrelli
Giuseppe Pontrelli
In this paper we present a general model of drug release from a drug delivery device and the subsequent transport in biological tissue. The model incorporates drug diffusion, dissolution and solubility in the polymer coating, coupled with diffusion, convection and reaction in the biological tissue. Each layer contains bound and free drug phases so that the resulting model is a coupled two-phase two-layer system of partial differential equations. One of the novelties is the generality of the model in each layer. Within the drug coating, our model includes diffusion as well as three different models of dissolution. We show that the model may also be used in cases where dissolution is rapid or not relevant, and additionally when drug release is not limited by its solubility. Within the biological tissue, the model can account for nonlinear saturable reversible binding, with linear reversible binding and linear irreversible binding being recovered as special cases. The generality of our model will allow the simulation of the release from a wide range of drug delivery devices encompassing many different applications. To demonstrate the efficacy of our model we simulate results for the particular application of drug release from arterial stents.

1 September 2010 in International Journal of Heat and Mass Transfer
Verified
Journal Article
Closed access
GPGiuseppe Pontrelli
Giuseppe Pontrelli
FMFilippo de Monte
Filippo de Monte

1 January 2009 in The European Physical Journal Special Topics
Verified
Journal Article
Closed access
PDF file
FDF. Diotallevi
F. Diotallevi
LBL. Biferale
L. Biferale
SCS. Chibbaro
S. Chibbaro
ALA. Lamura
A. Lamura
GPG. Pontrelli
G. Pontrelli
FTF. Toschi
F. Toschi

1 February 2018 in Computers in Biology and Medicine
Verified
Journal Article
Closed access
BKBadr Kaoui
Badr Kaoui
MLMarco Lauricella
Marco Lauricella
GPGiuseppe Pontrelli
Giuseppe Pontrelli